Current News
-
Antibody treatment allows transplant of mismatched stem cells, tissues in mice
If the antibody treatment is eventually found to be viable in humans, it could increase the numbers of people who benefit from hematopoietic stem transplants, Stanford researchers said.
-
Radiation-free stem cell transplants, gene therapy may be within reach
Researchers at Stanford and the University of Tokyo may have cracked the code to doing stem cell transplants and gene therapy without radiation and chemotherapy.
-
Scientists use CRISPR for possible 'bubble boy' therapy
In preclinical trials, Stanford scientists and their collaborators harnessed the gene-editing system CRISPR-Cas9 to replace the mutated gene underpinning the devastating immune disease.
-
Antibody could increase cure rate for blood, immune disorders
An antibody to a protein on blood-forming stem cells may allow bone marrow transplants without the need for chemotherapy and radiation, according to a Stanford study.
-
Antibody-drug combo may obviate need for tissue-matching in organ transplant
Researchers’ experimental approach for preparing mice for blood stem cell transplantation may one day make it possible in humans to safely transplant organs or cells from any donor to any recipient.
